相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neoantigen Immunotherapeutic-Gel Combined with TIM-3 Blockade Effectively Restrains Orthotopic Hepatocellular Carcinoma Progression
Qingfu Zhao et al.
NANO LETTERS (2022)
Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA
Xianming Zhang et al.
CELL REPORTS (2022)
Breast Cancer Induced Bone Osteolysis Prediction Using Temporal Variational Autoencoders
Wei Xiong et al.
BME FRONTIERS (2022)
Targeting herpes simplex virus with CRISPR-Cas9 cures herpetic stromal keratitis in mice
Di Yin et al.
NATURE BIOTECHNOLOGY (2021)
Is Viral Vector Gene Delivery More Effective Using Biomaterials?
Yi Wang et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Reprogramming the Tumor Microenvironment through Second-Near-Infrared-Window Photothermal Genome Editing of PD-L1 Mediated by Supramolecular Gold Nanorods for Enhanced Cancer Immunotherapy
Honglin Tang et al.
ADVANCED MATERIALS (2021)
Programmable Unlocking Nano-Matryoshka-CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response
Jin Yang et al.
ADVANCED SCIENCE (2021)
Cdk5 knocking out mediated by CRISPR-Cas9 genome editing for PD-L1 attenuation and enhanced antitumor immunity
Huan Deng et al.
ACTA PHARMACEUTICA SINICA B (2020)
Sustained Release of Decoy Wnt Receptor (sLRP6E1E2)-Expressing Adenovirus Using Gel-Encapsulation for Scar Remodeling in Pig Model
Chae-Eun Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Converting Immune Cold into Hot by Biosynthetic Functional Vesicles to Boost Systematic Antitumor Immunity
Ming Wu et al.
ISCIENCE (2020)
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
Lang Rao et al.
NATURE COMMUNICATIONS (2020)
Systemic cancer therapy with engineered adenovirus that evades innate immunity
Svetlana Atasheva et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Photo-Enhanced CRISPR/Cas9 System Enables Robust PD-L1 Gene Disruption in Cancer Cells and Cancer Stem-Like Cells for Efficient Cancer Immunotherapy
Liang Zhao et al.
SMALL (2020)
Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editors
Paul Boucher et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy
Qi Liu et al.
BIOMATERIALS (2020)
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
Han Yao et al.
NATURE BIOMEDICAL ENGINEERING (2019)
Genetically Engineered Cell Membrane Nanovesicles for Oncolytic Adenovirus Delivery: A Versatile Platform for Cancer Virotherapy
Peng Lv et al.
NANO LETTERS (2019)
Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination
Mathieu Grapin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
The Biomedical Use of Silk: Past, Present, Future
Chris Holland et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy
Huiya Huang et al.
NATURE COMMUNICATIONS (2019)
Spatial control of in vivo CRISPR-Cas9 genome editing via nanomagnets
Haibao Zhu et al.
NATURE BIOMEDICAL ENGINEERING (2019)
Artificially cloaked viral nanovaccine for cancer immunotherapy
Manlio Fusciello et al.
NATURE COMMUNICATIONS (2019)
Immunomodulatory injectable silk hydrogels maintaining functional islets and promoting anti-inflammatory M2 macrophage polarization
Manishekhar Kumar et al.
BIOMATERIALS (2018)
Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy
Wei-Jie Cheng et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10
Guo-Xiang Ruan et al.
MOLECULAR THERAPY (2017)
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L. Burr et al.
NATURE (2017)
Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
Kunwoo Lee et al.
NATURE BIOMEDICAL ENGINEERING (2017)
A hydrogel matrix prolongs persistence and promotes specific localization of an oncolytic adenovirus in a tumor by restricting nonspecific shedding and an antiviral immune response
Bo-Kyeong Jung et al.
BIOMATERIALS (2017)
CRISPR/Cas9: a historical and chemical biology perspective of targeted genome engineering
Amrita Singh et al.
CHEMICAL SOCIETY REVIEWS (2016)
Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus
Kristian Taipale et al.
MOLECULAR THERAPY (2016)
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Keiichiro Suzuki et al.
NATURE (2016)
Radiation-Induced Modulation of Costimulatory and Coinhibitory T-Cell Signaling Molecules on Human Prostate Carcinoma Cells Promotes Productive Antitumor Immune Interactions
Michael B. Bernstein et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2014)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Innate Immunity to Adenovirus
Rodinde Hendrickx et al.
HUMAN GENE THERAPY (2014)
CRISPR-mediated direct mutation of cancer genes in the mouse liver
Wen Xue et al.
NATURE (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
DM Roberts et al.
NATURE (2006)
Costimulatory molecule B7-H1 on primary and metastatic clear cell renal cell carcinoma
RH Thompson et al.
CANCER (2005)
Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery
Y Wang et al.
BRITISH JOURNAL OF CANCER (2005)
分享论文
